CVE-2026-48021In epa4all, prior to version 2026-05-20, an attacker who can intercept the TLS connection between epa4all and the ePA backend can complete the VAU handshake with attacker-controlled keys and obtain t…
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
In epa4all, prior to version 2026-05-20, an attacker who can intercept the TLS connection between epa4all and the ePA backend can complete the VAU handshake with attacker-controlled keys and obtain the session encryption keys. All inner HTTP traffic (patient consent decisions, medication data, document operations, authorization tokens, and entitlement queries) becomes readable and modifiable. The attacker can also inject arbitrary requests through the hijacked channel. This issue has been patched in version 2026-05-20.
- CVSS
- 9.1 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
- Weakness (CWE)
- CWE-295, CWE-347
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jul 30, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/med-united/epa4all/releases/tag/2026-05-20
- https://github.com/med-united/epa4all/security/advisories/GHSA-vvh7-x6c7-46gh
- https://www.machinespirits.com/advisory/aa49f0
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.